Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Acer truncatum Bunge seed oil is a botanical extract derived from the seeds of the Shantung maple (*Acer truncatum*), a tree native to East Asia. The oil is characterized by a high concentration of nervonic acid (cis-15-tetracosenoic acid), a long-chain monounsaturated fatty acid that is a vital component of the sphingolipids found in the myelin sheath of nerve fibers. It is primarily utilized as a nutraceutical or therapeutic agent for neurodegenerative diseases, including senile dementia (Alzheimer's disease) and multiple sclerosis, based on its purported ability to promote myelin repair, enhance cognitive function, and provide neuroprotection. Clinical studies have explored its efficacy as an adjunctive treatment alongside standard acetylcholinesterase inhibitors like donepezil to improve clinical outcomes in elderly patients with dementia.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on acer truncatum bunge seed oil.